Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOFEED: 1-Food vs 6-Food Diet in EoE
NCT02778867Phase 3Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- May 2016
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluticasone propionate in eosinophilic esophagitis (EoE) (4 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Percent of Participants in Histologic Remission (<15 Eos/Hpf) at 6 weeks. Started May 2016; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT02778867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02778867.